These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22426119)

  • 1. The potential of stem cell therapy for stroke: is PISCES the sign?
    Smith HK; Gavins FN
    FASEB J; 2012 Jun; 26(6):2239-52. PubMed ID: 22426119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cell therapy for subacute and chronic ischemic stroke.
    Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
    Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.
    Gervois P; Wolfs E; Ratajczak J; Dillen Y; Vangansewinkel T; Hilkens P; Bronckaers A; Lambrichts I; Struys T
    Med Res Rev; 2016 Nov; 36(6):1080-1126. PubMed ID: 27439773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-based therapies for ischemic stroke.
    Hao L; Zou Z; Tian H; Zhang Y; Zhou H; Liu L
    Biomed Res Int; 2014; 2014():468748. PubMed ID: 24719869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.
    Boese AC; Eckert A; Hamblin MH; Lee JP
    Exp Neurol; 2020 Jul; 329():113275. PubMed ID: 32147438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Stem Cells for Early Ischemic Stroke.
    Hamblin MH; Lee JP
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of stem cell-based therapies for stroke.
    Chrostek MR; Fellows EG; Crane AT; Grande AW; Low WC
    Brain Res; 2019 Nov; 1722():146362. PubMed ID: 31381876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stem cell therapy for ischemic stroke using iPS cells].
    Oki K
    Rinsho Shinkeigaku; 2013; 53(11):1017-9. PubMed ID: 24291865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of human induced pluripotent stem cells in experimental stroke.
    Chang DJ; Lee N; Park IH; Choi C; Jeon I; Kwon J; Oh SH; Shin DA; Do JT; Lee DR; Lee H; Moon H; Hong KS; Daley GQ; Song J
    Cell Transplant; 2013; 22(8):1427-40. PubMed ID: 23044029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?
    Sandu RE; Balseanu AT; Bogdan C; Slevin M; Petcu E; Popa-Wagner A
    Exp Gerontol; 2017 Aug; 94():73-77. PubMed ID: 28093317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Neurogenesis Following Ischemic Stroke and Implications for Cell-Based Therapeutic Approaches.
    Xie F; Liu H; Liu Y
    World Neurosurg; 2020 Jun; 138():474-480. PubMed ID: 32147554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells in stroke repair: current success and future prospects.
    Gopurappilly R; Pal R; Mamidi MK; Dey S; Bhonde R; Das AK
    CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):741-56. PubMed ID: 21838668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem Cell Therapies for Intracerebral Hemorrhage: Review of Preclinical and Clinical Studies.
    Takamiya S; Kawabori M; Fujimura M
    Cell Transplant; 2023; 32():9636897231158153. PubMed ID: 36823970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells for the treatment of stroke: the potential and the pitfalls.
    Yu F; Li Y; Morshead CM
    Curr Stem Cell Res Ther; 2013 Sep; 8(5):407-14. PubMed ID: 23895059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Therapeutic Potential of Induced Pluripotent Stem Cells After Stroke: Evidence from Rodent Models.
    Zents K; Copray S
    Curr Stem Cell Res Ther; 2016; 11(2):166-74. PubMed ID: 26216130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy for central nervous system disorders: Current obstacles to progress.
    Yasuhara T; Kawauchi S; Kin K; Morimoto J; Kameda M; Sasaki T; Bonsack B; Kingsbury C; Tajiri N; Borlongan CV; Date I
    CNS Neurosci Ther; 2020 Jun; 26(6):595-602. PubMed ID: 31622035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model.
    Baker EW; Platt SR; Lau VW; Grace HE; Holmes SP; Wang L; Duberstein KJ; Howerth EW; Kinder HA; Stice SL; Hess DC; Mao H; West FD
    Sci Rep; 2017 Aug; 7(1):10075. PubMed ID: 28855627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte depletion early after stroke promotes neurogenesis from endogenous neural stem cells in adult brain.
    Laterza C; Wattananit S; Uoshima N; Ge R; Pekny R; Tornero D; Monni E; Lindvall O; Kokaia Z
    Exp Neurol; 2017 Nov; 297():129-137. PubMed ID: 28746827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential benefit of stem cell therapy after stroke: an update.
    Banerjee S; Williamson DA; Habib N; Chataway J
    Vasc Health Risk Manag; 2012; 8():569-80. PubMed ID: 23091389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Analysis of the Safety and Efficacy of Stem Cell Therapies for Ischemic Stroke in Preclinical and Clinical Studies.
    Ouyang Q; Li F; Xie Y; Han J; Zhang Z; Feng Z; Su D; Zou X; Cai Y; Zou Y; Tang Y; Jiang X
    Stem Cells Dev; 2019 Apr; 28(8):497-514. PubMed ID: 30739594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.